AQST
Price
$3.72
Change
+$0.04 (+1.09%)
Updated
Jul 3 closing price
Capitalization
383.26M
39 days until earnings call
SCYX
Price
$0.73
Change
+$0.01 (+1.39%)
Updated
Jul 3 closing price
Capitalization
55.88M
44 days until earnings call
Interact to see
Advertisement

AQST vs SCYX

Header iconAQST vs SCYX Comparison
Open Charts AQST vs SCYXBanner chart's image
Aquestive Therapeutics
Price$3.72
Change+$0.04 (+1.09%)
Volume$625.35K
Capitalization383.26M
SCYNEXIS
Price$0.73
Change+$0.01 (+1.39%)
Volume$70.95K
Capitalization55.88M
AQST vs SCYX Comparison Chart in %
Loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AQST vs. SCYX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQST is a StrongBuy and SCYX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (AQST: $3.72 vs. SCYX: $0.73)
Brand notoriety: AQST and SCYX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AQST: 39% vs. SCYX: 58%
Market capitalization -- AQST: $383.26M vs. SCYX: $55.88M
AQST [@Pharmaceuticals: Other] is valued at $383.26M. SCYX’s [@Pharmaceuticals: Other] market capitalization is $55.88M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AQST’s FA Score shows that 0 FA rating(s) are green whileSCYX’s FA Score has 0 green FA rating(s).

  • AQST’s FA Score: 0 green, 5 red.
  • SCYX’s FA Score: 0 green, 5 red.
According to our system of comparison, AQST is a better buy in the long-term than SCYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AQST’s TA Score shows that 6 TA indicator(s) are bullish while SCYX’s TA Score has 4 bullish TA indicator(s).

  • AQST’s TA Score: 6 bullish, 4 bearish.
  • SCYX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AQST is a better buy in the short-term than SCYX.

Price Growth

AQST (@Pharmaceuticals: Other) experienced а +14.46% price change this week, while SCYX (@Pharmaceuticals: Other) price change was -0.69% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

AQST is expected to report earnings on Aug 12, 2025.

SCYX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AQST($383M) has a higher market cap than SCYX($55.9M). AQST YTD gains are higher at: 4.494 vs. SCYX (-39.554). SCYX has higher annual earnings (EBITDA): 70.9M vs. AQST (1.18M). SCYX has more cash in the bank: 74.4M vs. AQST (23.9M). SCYX has less debt than AQST: SCYX (15.1M) vs AQST (33.3M). SCYX has higher revenues than AQST: SCYX (140M) vs AQST (50.6M).
AQSTSCYXAQST / SCYX
Capitalization383M55.9M685%
EBITDA1.18M70.9M2%
Gain YTD4.494-39.554-11%
P/E RatioN/A1.06-
Revenue50.6M140M36%
Total Cash23.9M74.4M32%
Total Debt33.3M15.1M221%
FUNDAMENTALS RATINGS
AQST vs SCYX: Fundamental Ratings
AQST
SCYX
OUTLOOK RATING
1..100
2454
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
3991
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
8536

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AQST's Valuation (39) in the Pharmaceuticals Major industry is in the same range as SCYX (54) in the Pharmaceuticals Other industry. This means that AQST’s stock grew similarly to SCYX’s over the last 12 months.

AQST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SCYX (100) in the Pharmaceuticals Other industry. This means that AQST’s stock grew similarly to SCYX’s over the last 12 months.

SCYX's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that SCYX’s stock grew similarly to AQST’s over the last 12 months.

AQST's Price Growth Rating (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for SCYX (91) in the Pharmaceuticals Other industry. This means that AQST’s stock grew somewhat faster than SCYX’s over the last 12 months.

SCYX's P/E Growth Rating (99) in the Pharmaceuticals Other industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that SCYX’s stock grew similarly to AQST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AQSTSCYX
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 23 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLLDY10.340.09
+0.88%
Sanlam Ltd.
YNSKF0.03N/A
N/A
King Stone Energy Group Ltd.
JXFGF0.28N/A
N/A
JINXIN FERTILITY GROUP LTD.
TNREF0.15N/A
N/A
Taranis Resources Inc.
CFRUY18.88-0.22
-1.15%
Compagnie Financiere Richemont AG

AQST and

Correlation & Price change

A.I.dvisor indicates that over the last year, AQST has been loosely correlated with SCYX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if AQST jumps, then SCYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQST
1D Price
Change %
AQST100%
+1.09%
SCYX - AQST
36%
Loosely correlated
+1.57%
DERM - AQST
31%
Poorly correlated
+1.87%
OGI - AQST
31%
Poorly correlated
+3.62%
TLRY - AQST
30%
Poorly correlated
+11.03%
CRDL - AQST
29%
Poorly correlated
+10.79%
More

SCYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCYX has been loosely correlated with AQST. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if SCYX jumps, then AQST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+1.57%
AQST - SCYX
36%
Loosely correlated
+1.09%
CRON - SCYX
30%
Poorly correlated
+2.00%
AKAN - SCYX
30%
Poorly correlated
+5.38%
TLRY - SCYX
29%
Poorly correlated
+11.03%
ACB - SCYX
29%
Poorly correlated
+1.57%
More